Search Ontology:
ChEBI

vaniprevir

Term ID
CHEBI:136047
Synonyms
  • (5R,7S,10S)-10-tert-butyl-N-{(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethylcyclopropyl}-15,15-dimethyl-3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-dodecahydro-1H,5H-2,23:5,8-dimethano-4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-carboxamide
  • MK 7009
  • MK-7009
  • MK7009
  • Vanihep
  • vaniprevir
  • vaniprevirum
Definition
An azamacrocyclic compound that is a hepatitis C virus (HCV) NS3/4A protease inhibitor which is approved for the treatment of hepatitis C virus infections in Japan.
References
  • cas:923590-37-8
  • chemspider:28475381
  • drugbank:DB11929
  • drugcentral:4939
  • kegg.drug:D09987
  • pdb-ccd:SU3
  • pubmed:19328051
  • pubmed:19841155
  • pubmed:20163176
  • pubmed:21838271
  • pubmed:22458448
  • pubmed:22473713
  • pubmed:22910833
  • pubmed:23439259
  • pubmed:23745769
  • pubmed:23747481
  • pubmed:23763767
  • pubmed:24120953
  • pubmed:25000830
  • pubmed:25115901
  • pubmed:25849338
  • pubmed:26354016
  • pubmed:26403160
  • pubmed:26569595
  • pubmed:26845940
  • pubmed:26936417
  • pubmed:26947564
  • pubmed:27512818
  • pubmed:28677966
  • pubmed:28796416
  • pubmed:31868916
  • wikipedia.en:Vaniprevir
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from vaniprevir
Phenotype where environments contain vaniprevir
Phenotype modified by environments containing vaniprevir
Phenotype affecting vaniprevir
Human Disease Model